Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction - Top-Institutions - MDSpire

Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction

  • By

  • Wei Gu

  • Chengyin Xu

  • Jinzhen Fu

  • Huijun Lei

  • Najeeb Ullah Khan

  • Ruijiao Lei

  • Xukai Chen

  • Xiao-jia Wang

  • Tianhui Chen

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Women’s College Research Institute
    Women’s College Research Institute

    Toronto, Ontario

    Key Differentiators

    • Oncology

  • #2

    University of Toronto
    University of Toronto

    Toronto, Ontario

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #4

    Zhejiang Cancer Hospital
    Zhejiang Cancer Hospital

    Hangzhou, Zhejiang

    Key Differentiators

    • Oncology

Original Source(s)

Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction

  • by Wei Gu, Chengyin Xu, Jinzhen Fu, Huijun Lei, Najeeb Ullah Khan, Ruijiao Lei, Xukai Chen, Xiao-jia Wang, Tianhui Chen

  • June 2, 2026

Related Content

Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening